FIELD: biotechnology.
SUBSTANCE: invention relates to a method of producing a bispecific antigen-binding polypeptide structure. Said structure comprises first (H1L1) and second (H2L2) heterodimers, wherein the first heterodimer comprises a first Fab region that specifically binds to the first antigen; and the second heterodimer (H2L2) comprises a second Fab region which specifically binds to a second antigen. Disclosed method comprises the following steps: 1) introduction of one or more substitutions into polynucleotides coding H1, H2, L1, L2; 2) introduction of said polynucleotides into a host cell and its cultivation; 3) collecting a bispecific antigen-binding polypeptide structure.
EFFECT: present invention provides antigen-binding polypeptides containing a light chain of immunoglobulin lambda and a light chain of immunoglobulin kappa, obtained using complementary amino acid modifications.
8 cl, 16 dwg, 25 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONSTRUCTED PAIRS OF HEAVY-LIGHT IMMUNOGLOBULIN CHAINS AND THEIR USE | 2013 |
|
RU2720472C2 |
| VERSIONS OF PERTUZUMAB AND THEIR ANALYTICAL CHARACTERISTICS | 2014 |
|
RU2737727C2 |
| HER-2-DIRECTED ANTIGEN-BINDING MOLECULES CONTAINING 4-1BBL | 2019 |
|
RU2815451C2 |
| METHODS OF PRODUCING AND USING GUIDE AND NAVIGATION CONTROL PROTEINS | 2019 |
|
RU2824896C2 |
| MANAGEMENT, NAVIGATION AND CONTROL PROTEINS AND METHOD OF THEIR OBTAINING AND USE | 2019 |
|
RU2811457C2 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| LY6G6D ANTIBODIES AND METHODS OF USE | 2020 |
|
RU2818569C1 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2800779C2 |
| ANTIBODIES AGAINST PD-L1 AND THEIR OPTIONS | 2017 |
|
RU2770590C2 |
| ANTI-LILRB1 ANTIBODY AND ITS USE | 2020 |
|
RU2801535C1 |
